about
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?New antidepressants or more of the same?A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treatExpanding the horizons of depression: beyond the monoamine hypothesis.
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
On the feasibility of designing new antidepressants.
@ast
On the feasibility of designing new antidepressants.
@en
type
label
On the feasibility of designing new antidepressants.
@ast
On the feasibility of designing new antidepressants.
@en
prefLabel
On the feasibility of designing new antidepressants.
@ast
On the feasibility of designing new antidepressants.
@en
P2860
P356
P1476
On the feasibility of designing new antidepressants.
@en
P2093
Roger M Pinder
P2860
P356
10.1002/HUP.183
P577
2001-01-01T00:00:00Z